Fungal and host protein persulfidation are functionally correlated and modulate both virulence and antifungal response

From PLOS via Jisc Publications RouterHistory: received 2020-06-02, accepted 2021-04-27, collection 2021-06, epub 2021-06-01Publication status: PublishedFunder: Medical Research Council; funder-id: http://dx.doi.org/10.13039/501100000265; Grant(s): MR/N008707/1Funder: National Centre for the Replacement, Refinement and Reduction of Animals in Research; funder-id: http://dx.doi.org/10.13039/501100000849; Grant(s): NC/P002390/1Funder: Fundação para a Ciência e a Tecnologia; funder-id: http://dx.doi.org/10.13039/501100001871; Grant(s): SFRH/BPD/96176/201Funder: Fundação para a Ciência e a Tecnologia; funder-id: http://dx.doi.org/10.13039/501100001871; Grant(s): IF/00735/2014Funder: deutsche forschungsgemeinschaft; Grant(s): CRC/TRR 124Funder: Fondation de l'Avenir pour la Recherche Médicale Appliquée; funder-id: http://dx.doi.org/10.13039/100007380Aspergillus fumigatus is a human fungal pathogen that can cause devastating pulmonary infections, termed “aspergilloses,” in individuals suffering immune imbalances or underlying lung conditions. As rapid adaptation to stress is crucial for the outcome of the host–pathogen interplay, here we investigated the role of the versatile posttranslational modification (PTM) persulfidation for both fungal virulence and antifungal host defense. We show that an A. fumigatus mutant with low persulfidation levels is more susceptible to host-mediated killing and displays reduced virulence in murine models of infection. Additionally, we found that a single nucleotide polymorphism (SNP) in the human gene encoding cystathionine γ-lyase (CTH) causes a reduction in cellular persulfidation and correlates with a predisposition of hematopoietic stem cell transplant recipients to invasive pulmonary aspergillosis (IPA), as correct levels of persulfidation are required for optimal antifungal activity of recipients’ lung resident host cells. Importantly, the levels of host persulfidation determine the levels of fungal persulfidation, ultimately reflecting a host–pathogen functional correlation and highlighting a potential new therapeutic target for the treatment of aspergillosis

LA COMPETITIVIDAD DE LAS EMPRESAS DE TELEFONÍA MÓVIL UN ESTUDIO COMPARATIVO MÉXICO, ARGENTINA Y FRANCIA 1990-2013

En el presente trabajo de investigación se hace un estudio comparativo de la competitividad de las empresas de telefonía móvil tomando en consideración el contexto europeo, concretamente lo que ocurre en Francia, en donde el proceso de privatización del sector de telecomunicaciones se dio bajo un marco regulatorio más equitativo para todos los competidores, impulsando a las empresas a tratar de alcanzar una posición competitiva favorable; logrando así el sano desarrollo del mercado, donde la cuota de cada operador se determina por su competitividad más que por el entorno regulatorio. Posteriormente se consideran en el estudio, los casos de México y Argentina para tratar de sondear la situación de América Latina, de manera que se analizan los cambios regulatorios, la situación de la industria y los recursos y capacidades de las empresas del ramo, para observar su desempeño en el mercado. Ya que en algunos casos como México y Argentina, el contexto regulatorio en el que se desarrolló el proceso de privatización colocó a algunos competidores domésticos en situación de desventaja ante los nuevos entrantes, propiciando así la creación de monopolios legales, caracterizados por tener altas tarifas, retraso tecnológico lo que incidió en una baja penetración en el mercado. En este escenario, resulta interesante averiguar si la posición que actualmente tienen las grandes empresas de telefonía móvil en Latinoamérica y en Europa particularmente en México, Argentina y Francia, se debe a su nivel de competitividad o al contexto en el éstas surgieron y el tipo de competencia que opera en cada mercado. Además, de conocer si son los factores internos de cada empresa los que influyen 9 predominantemente en su posición competitiva o bien si son las características del mercado las que la determinan

Targeting methionine synthase in a fungal pathogen causes a metabolic imbalance that impacts cell energetics, growth and virulence

There is an urgent need to develop novel antifungals to tackle the threat fungal pathogens pose to human health. Here, we have performed a comprehensive characterization and validation of the promising target methionine synthase (MetH). We show that in Aspergillus fumigatus the absence of this enzymatic activity triggers a metabolic imbalance that causes a reduction in intracellular ATP, which prevents fungal growth even in the presence of methionine. Interestingly, growth can be recovered in the presence of certain metabolites, which shows that metH is a conditionally essential gene and consequently should be targeted in established infections for a more comprehensive validation. Accordingly, we have validated the use of the tetOFF genetic model in fungal research and improved its performance in vivo to achieve initial validation of targets in models of established infection. We show that repression of metH in growing hyphae halts growth in vitro, which translates into a beneficial effect when targeting established infections using this model in vivo Finally, a structure-based virtual screening of methionine synthases reveals key differences between the human and fungal structures and unravels features in the fungal enzyme that can guide the design of novel specific inhibitors. Therefore, methionine synthase is a valuable target for the development of new antifungals. IMPORTANCE Fungal pathogens are responsible for millions of life-threatening infections on an annual basis worldwide. The current repertoire of antifungal drugs is very limited and, worryingly, resistance has emerged and already become a serious threat to our capacity to treat fungal diseases. The first step to develop new drugs is often to identify molecular targets in the pathogen whose inhibition during infection can prevent its growth. However, the current models are not suitable to validate targets in established infections. Here, we have characterized the promising antifungal target methionine synthase in great detail, using the prominent fungal pathogen Aspergillus fumigatus as a model. We have uncovered the underlying reason for its essentiality and confirmed its druggability. Furthermore, we have optimized the use of a genetic system to show a beneficial effect of targeting methionine synthase in established infections. Therefore, we believe that antifungal drugs to target methionine synthase should be pursued and additionally, we provide a model that permits gaining information about the validity of antifungal targets in established infections

Fungal and host protein persulfidation are functionally correlated and modulate both virulence and antifungal response

This is the final version. Available on open access from the Public Library of Science via the DOI in this recordData Availability: All raw data that support the findings of this study is available in the supplementary figures, tables and datasets.Aspergillus fumigatus is a human fungal pathogen that can cause devastating pulmonary infections, termed “aspergilloses,” in individuals suffering immune imbalances or underlying lung conditions. As rapid adaptation to stress is crucial for the outcome of the host–pathogen interplay, here we investigated the role of the versatile posttranslational modification (PTM) persulfidation for both fungal virulence and antifungal host defense. We show that an A. fumigatus mutant with low persulfidation levels is more susceptible to host-mediated killing and displays reduced virulence in murine models of infection. Additionally, we found that a single nucleotide polymorphism (SNP) in the human gene encoding cystathionine γ-lyase (CTH) causes a reduction in cellular persulfidation and correlates with a predisposition of hematopoietic stem cell transplant recipients to invasive pulmonary aspergillosis (IPA), as correct levels of persulfidation are required for optimal antifungal activity of recipients’ lung resident host cells. Importantly, the levels of host persulfidation determine the levels of fungal persulfidation, ultimately reflecting a host–pathogen functional correlation and highlighting a potential new therapeutic target for the treatment of aspergillosis.Medical Research Council (MRC)National Institute for Health Research (NIHR)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)European Regional Development Fund (FEDER)Fundação para a Ciência e TecnologiaDeutsche Forschungsgemeinschaft (DFG)La Science Pour la Santé ATIP AvenirFondation pour la Recherche Médicale (FRM

A possible role for fumagillin in cellular damage during host infection by Aspergillus fumigatus.

Virulence mechanisms of the pathogenic fungus Aspergillus fumigatus are multifactorial and depend on the immune state of the host, but little is known about the fungal mechanism that develops during the process of lung invasion. In this study, microarray technology was combined with a histopathology evaluation of infected lungs so that the invasion strategy followed by the fungus could be described. To achieve this, an intranasal mice infection was performed to extract daily fungal samples from the infected lungs over four days post-infection. The pathological study revealed a heavy fungal progression throughout the lung, reaching the blood vessels on the third day after exposure and causing tissue necrosis. One percent of the fungal genome followed a differential expression pattern during this process. Strikingly, most of the genes of the intertwined fumagillin/pseurotin biosynthetic gene cluster were upregulated as were genes encoding lytic enzymes such as lipases, proteases (DppIV, DppV, Asp f 1 or Asp f 5) and chitinase (chiB1) as well as three genes related with pyomelanin biosynthesis process. Furthermore, we demonstrate that fumagillin is produced in an in vitro pneumocyte cell line infection model and that loss of fumagillin synthesis reduces epithelial cell damage. These results suggest that fumagillin contributes to tissue damage during invasive aspergillosis. Therefore, it is probable that A. fumigatus progresses through the lungs via the production of the mycotoxin fumagillin combined with the secretion of lytic enzymes that allow fungal growth, angioinvasion and the disruption of the lung parenchymal structure

A possible role for fumagillin in cellular damage during host infection by Aspergillus fumigatus.

Virulence mechanisms of the pathogenic fungus Aspergillus fumigatus are multifactorial and depend on the immune state of the host, but little is known about the fungal mechanism that develops during the process of lung invasion. In this study, microarray technology was combined with a histopathology evaluation of infected lungs so that the invasion strategy followed by the fungus could be described. To achieve this, an intranasal mice infection was performed to extract daily fungal samples from the infected lungs over four days post-infection. The pathological study revealed a heavy fungal progression throughout the lung, reaching the blood vessels on the third day after exposure and causing tissue necrosis. One percent of the fungal genome followed a differential expression pattern during this process. Strikingly, most of the genes of the intertwined fumagillin/pseurotin biosynthetic gene cluster were upregulated as were genes encoding lytic enzymes such as lipases, proteases (DppIV, DppV, Asp f 1 or Asp f 5) and chitinase (chiB1) as well as three genes related with pyomelanin biosynthesis process. Furthermore, we demonstrate that fumagillin is produced in an in vitro pneumocyte cell line infection model and that loss of fumagillin synthesis reduces epithelial cell damage. These results suggest that fumagillin contributes to tissue damage during invasive aspergillosis. Therefore, it is probable that A. fumigatus progresses through the lungs via the production of the mycotoxin fumagillin combined with the secretion of lytic enzymes that allow fungal growth, angioinvasion and the disruption of the lung parenchymal structure